Improving regulatory efficiency for biotechnology products
- PMID: 38303910
- PMCID: PMC10830748
- DOI: 10.3389/fbioe.2024.1354743
Improving regulatory efficiency for biotechnology products
Abstract
Small procedural changes in how regulatory agencies implement biotech policies can make significant differences in improving regulatory efficiency. This paper discusses how science based, crop specific guidance documents can improve dossier content and the review and approval of biotech varieties. In addition, we describe how the adoption of established risk assessment methodology and applying policy-linked decision making at the agency level can boost both efficiency and developer, public and government confidence in agency decision making and in biotech crops.
Keywords: data requirements; decision making; regulation; regulatory efficiency; risk assessment.
Copyright © 2024 Koch, Pence, DeMond and Rudgers.
Conflict of interest statement
Authors MK, MP, JD, and GR were employed by J. R. Simplot Company.
Figures
References
-
- AgbioInvestor (2022). Time and cost to develop a new GM trait. Study report. Available at: https://agbioinvestor.com/wp-content/uploads/2022/05/AgbioInvestor-Time-... (Accessed December 8, 2023).
-
- Bachman P. M., Anderson J., Burns A., Chakravarthy S., Goodwin L., Privalle L., et al. (2021). Data transportability for studies performed to support an environmental risk assessment for genetically modified (GM) crops. J. Reg. Sci. 9 (1), 38–44. 10.21423/jrs-v09i1bachman - DOI
-
- ISAAA (2019). “Global status of commercialized biotech/GM crops in 2019: biotech crops drive socio-economic development and sustainable environment in the New Frontier,” in ISAAA brief No. 55 (Ithaca, New York: ISAAA; ).
-
- Ministry of Agriculture and Rural Development (2014). MARD circular 2/2014/TT-BNNPTNT. Government of Vietnam. Available at: https://www.mard.gov.vn (Accessed January 2, 2024).
LinkOut - more resources
Full Text Sources
